The 'shock and kill' therapeutic strategy for treating HIV could potentially cause harmful neuroinflammation, a new study reveals.
Researchers report the median time from exposure to symptoms for the COVID-19 virus is 5.1 days. 97.5% of people who develop symptoms of coronavirus will do so within 11.5 days of exposure. For every 10,000 people quarantined for 14 days, an estimated 101 would develop symptoms after release.
Infectious disease experts report between 40% and 70% of adults could become infected with coronavirus during the outbreak. In a new interview, Dr. Lipsitch, head of Harvard's T.H. Chan School of Public Health's Center for Communicable Disease Dynamics, discusses the risks and spread potential of COVID-19, and addresses how the infection could impact children's' health.
Combining a tetanus vaccine with a virus particle may prove effective as a protection against Alzheimer's. The vaccine could also be used to treat allergies and psoriasis, researchers report.
Chikungunya, and other mosquito-borne alphaviruses are known to trigger brain infections and arthritis in those who contract the infections. Researchers have identified two antibodies that protect animals from diseases caused by alphaviruses. The findings could pave the way to new treatments and a universal vaccine for alphaviruses.
According to a new study, brain cells lining blood vessels produce a protein that impairs neuronal firing in the hippocampus during an antiviral immune response.
Retroviruses may be a missing causal link in diseases like ALS, multiple sclerosis and schizophrenia.
Researchers discover a link between genital herpes infections during pregnancy and an increased risk of autism in the offspring.
WUSTL researchers report viruses such as West Nile and Zika can kill neurons in the gut, disrupting bowel movements and causing intestinal blockages.
A new study reveals viruses can disable the production of Foxj1, causing ependymal cells to lose their structure, sparking hydrocephalus.
According to researchers, our senses of smell and vision make us aware that someone is on the verge of sickness, even before symptoms appear.
Researchers report RIPK3 appears to protect brain cells during West Nile virus infection.
